Brain organoids have emerged as powerful tools for studying human neurological disease. By generating three-dimensional neural tissue from human stem cells, researchers can investigate aspects of brain development and disease that are difficult to replicate in traditional 2D cell cultures or animal models.
But an important question remains: How well does an organoid model what actually happens in the human brain?
This is the central challenge of organoid translation.
Researchers commonly validate organoids by examining their cellular composition, gene expression, morphology, and developmental characteristics. These measurements can demonstrate that an organoid contains relevant cell types and molecular features associated with human brain tissue.
However, biological similarity does not necessarily mean functional similarity.
Neurological diseases frequently involve changes in how neurons communicate and how neural networks function. A disease model may show differences in gene expression or cellular structure while failing to capture important changes in neuronal activity. Conversely, subtle functional abnormalities may exist before major structural changes become apparent.
For this reason, incorporating functional measurements into disease modeling can provide an important additional layer of validation.
Electrophysiology provides a direct way to measure the electrical activity of neurons and neural networks. Measurements such as neuronal firing, network synchronization, and local field potentials can reveal how neural circuits behave under healthy, diseased, or drug-treated conditions.
For organoid models, where neurons are distributed throughout a three-dimensional tissue, where that activity is measured also matters.
Surface-based approaches can provide valuable information about neurons near the recording interface, but they may not capture activity occurring deeper within an intact organoid. Accessing neural activity at multiple depths can provide a more complete picture of how functional networks develop and respond to disease or treatment.
Improving the translational potential of organoids requires integrating multiple types of data rather than relying on a single measurement. Molecular biomarkers can reveal changes in gene expression, imaging can characterize cellular structure, and electrophysiology can provide insight into physiological function.
Together, these measurements can create a more comprehensive profile of a disease phenotype and potentially improve the predictive value of organoid models for therapeutic research.
SomaFocus™ supports this approach by enabling automated electrophysiological recordings from within intact brain organoids. By measuring neuronal spiking and local field potentials across multiple depths, researchers can evaluate functional neural activity while maintaining the organoid's three-dimensional architecture.
As translational neuroscience continues to move toward more human-relevant models, the goal is not simply to create organoids that look like human brain tissue. It is to develop models that also reproduce meaningful aspects of human neural function.
The more comprehensively researchers can measure these functional characteristics, the better positioned they are to understand disease mechanisms, identify meaningful biomarkers, and evaluate potential therapies in models designed to bridge the gap between laboratory research and human disease.